Natera announced the launch of a proposed follow-on public offering of $250M of shares of its common stock. Morgan Stanley, Goldman Sachs & Co., TD Cowen and Piper Sandler are acting as joint book-running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NTRA:
- Natera: Prospera lung transplant assessment test granted Medicare coverage
- Natera price target raised to $80 from $70 at Piper Sandler
- CareDx says district court judge issues injunction against Natera
- Natera raises FY23 revenue view from $995M-$1.015B to $1.015B-$1.035B
- Natera reports Q2 EPS (97c), consensus ($1.09)